Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Catheter Ablation vs. Antiarrhythmic Drugs and Risk Factor Modification. PRAGUE-25 Randomized Study

NCT04011800 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT04011800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04011800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Catheter Ablation vs. Antiarrhythmic Drugs and Risk Factor Modification. PRAGUE-25 Randomized Study
Lead sponsor
Charles University, Czech Republic
Phase
Phase 3
Overall status
Unknown status
Start date
May 1, 2021
Completion date
December 30, 2025
Enrollment
212 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation